Currently, there are 769.67M common shares owned by the public and among those 751.62M shares have been available to trade.
The company’s stock has a 5-day price change of 8.88% and 44.89% over the past three months. XPEV shares are trading 53.47% year to date (YTD), with the 12-month market performance up to 99.78% higher. It has a 12-month low price of $6.55 and touched a high of $19.36 over the same period. XPEV has an average intraday trading volume of 10.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 10.08%, 26.82%, and 69.20% respectively.
Institutional ownership of XPeng Inc ADR (NYSE: XPEV) shares accounts for 16.29% of the company’s 769.67M shares outstanding.
It has a market capitalization of $14.04B and a beta (3y monthly) value of 2.74. The earnings-per-share (ttm) stands at -$0.86. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.71% over the week and 4.31% over the month.
Analysts forecast that XPeng Inc ADR (XPEV) will achieve an EPS of -1.45 for the current quarter, -1.15 for the next quarter and -3.07 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -1.57 while analysts give the company a high EPS estimate of -1.57. Comparatively, EPS for the current quarter was -1.98 a year ago. Earnings per share for the fiscal year are expected to increase by 63.81%, and 56.34% over the next financial year.
Looking at the support for the XPEV, a number of firms have released research notes about the stock. UBS stated their Neutral rating for the stock in a research note on Feb-25-25, with the firm’s price target at $8.80-$18. Macquarie coverage for the XPeng Inc ADR (XPEV) stock in a research note released on February 07, 2025 offered a Neutral rating with a price target of $18. UBS was of a view on December 05, 2024 that the stock is Sell, while China Renaissance gave the stock Buy rating on November 22, 2024, issuing a price target of $16.70. Goldman on their part issued Neutral rating on November 21, 2024.
